我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

经导管二尖瓣植入术的进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2017年第4期
页码:
482-486
栏目:
综述
出版日期:
2017-02-25

文章信息/Info

Title:
Development of Transcatheter Mitral Valve Implantation
作者:
杨东涛1; 何晓菊1 综述; 杨 剑2 审校
1.解放军538医院内一科，陕西 汉中 723102；2.第四军医大学西京医院心血管外科，陕西 西安 710032
Author(s):
YANG Dong-tao1;  HE Xiao-ju1;  YANG Jian2
1.Department of Cardiology, 538 Hospital of the PLA, Hanzhong 723102, Shaanxi,China; 2.Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China
关键词:
二尖瓣返流; 经导管二尖瓣植入; 介入治疗
Keywords:
mitral regurgitation;  transcatheter mitral valve implantation;  transcatheter intervention
分类号:
R542.5
DOI:
-
文献标识码:
A
摘要:
二尖瓣关闭不全是最为常见的瓣膜疾病之一。近年来，介入技术在经导管二尖瓣置换方面取得了巨大进展。国内外目前已有Tiara等5种介入二尖瓣系统成功应用于临床，并有少量病例报道，同时有近20家公司和医疗机构进行相关器材和设备的研发，初步的研究结果显示具有良好安全性和有效性。虽然仍有一些尚待解决的问题，相信随着研究的深入，经导管二尖瓣置换必将逐步走向成熟，在治疗二尖瓣关闭不全上取得新的突破，为更多的患者提供一种微创、有效、安全的治疗手段。本文针对经导管二尖瓣植入术的可行性、安全性等方面进行全面综述。
Abstract:
Mitral regurgitation is one of the most common valve disease. In recent years, progress has been made in the field of transcatheter mitral valve implantation. Up to now, transcatheter mitral valve implantation has been applied in clinical practice and there were few reports of various devices. More than 20 companies together with medical centers are developing different types of transcatheter mitral valve devices. In this paper, we reviewed the feasibility, safety and efficacy of transcatheter mitral valve implantation. The preliminary results indicate that it has good safety and effectiveness. Although there are still some problems to be solved, we believe that with the in-depth study, transcatheter mitral valve replacement will gradually mature. With new breakthroughs in the treatment of mitral valve, more and more patients will benefit from this mini-invasive approach. This comprehensive review focus mainly on the feasibility and safety of transcatheter mitral valve implantation.

参考文献/References

[1]Taramasso M,Gaemperli O,Maisano F.Treatment of degenerative mitral regurgitation in elderly patients[J].Nat Rev Cardiol,2015,12(3):177-183.
[2]Tsuneyoshi H,Komeda M.Update on mitral valve surgery[J].J Artif Organs,2005, 8(4):222-227.
[3]Ludman PF,Moat N,de Belder MA,et al.Transcatheter aortic valve implantation in the united kingdom:Temporal trends, predictors of outcome,and 6-year follow-up:A report from the uk transcatheter aortic valve implantation(tavi)registry,2007 to 2012[J].Circulation,2015,131(13):1181-1190.
[4]Bourantas CV,Serruys PW.Evolution of transcatheter aortic valve replacement[J].Circ Res,2014,114(16):1037-1051.
[5]Mylotte D,Piazza N.Transcatheter mitral valve implantation:A brief review[J].Eurointervention,2015,11(Suppl W):W67-W70.
[6]Sondergaard L,De Backer O,Franzen OW,et al.First-in-Human Case of Transfemoral CardiAQ Mitral Valve Implantation[J].Circ Cardiovasc Interv,2015,8(7):e002135.
[7]Buzzatti N,Taramasso M,Latib A,et al.Transcatheter mitral repair and replacement:State of the art and future directions[J].J Heart Valve Dis,2014,23(4):492-505.
[8]Verheye S,Cheung A,Leon M,et al.The tiara transcatheter mitral valve implantation system[J].Eurointervention,2015,11(Suppl W):W71-W72.
[9]Banai S,Verheye S,Cheung A,et al.Transapical mitral implantation of the tiara bioprosthesis:Pre-clinical results[J].JACC Cardiovasc Interv,2014,7(2):154-162.
[10]Cheung A,Stub D,Moss R,et al.Transcatheter mitral valve implantation with tiara bioprosthesis[J].Eurointervention,2014,10(Suppl U):U115-U119.
[11]Bapat V,Lim ZY,Boix R,et al.The edwards fortis transcatheter mitral valve implantation system[J].Eurointervention,2015,11(Suppl W):W73-W75.
[12]Bapat V,Buellesfeld L,Peterson MD,et al.Transcatheter mitral valve implantation（TMVI）using the edwards fortis device[J].Eurointervention,2014,10(Suppl U):U120-U128.
[13]Abdul-Jawad Altisent O,Dumont E,Dagenais F,et al.Transcatheter mitral valve implantation with the fortis device:Insights into the evaluation of device success[J].JACC Cardiovasc Interv,2015,8(7):994-995.
[14]Ussia GP,Quadri A,Cammalleri V,et al.Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQTM mitral valve bioprosthesis:first procedure description and 30-day follow-up[J].EuroIntervention,2016,11(10):1126-1151.
[15]Sondergaard L,Ussia GP,Dumonteil N,et al.The cardiaq transcatheter mitral valve implantation system[J].EuroIntervention,2015,11(Suppl W):W76-W77.
[16]Sondergaard L,Brooks M,Ihlemann N,et al.Transcatheter mitral valve implantation via transapical approach: an early experience[J].Eur J Cardiothorac Surg,2015,48(6):873-878.
[17]Perpetua EM,Reisman M.The tendyne transcatheter mitral valve implantation system[J].EuroIntervention,2015,11(Suppl W):W78-W79.
[18]Abdelghani M,Onuma Y,Zeng Y,et al.The sino medical accufit transcatheter mitral valve implantation system[J].EuroIntervention,2015,11(Suppl W):W84-W85.
[19]Zamorano JL,Gonzalez-Gomez A,Lancellotti P.Mitral valve anatomy:Implications for transcatheter mitral valve interventions[J].EuroIntervention,2014,10(Suppl U):U106-U111.
[20]Maisano F,Alfieri O,Banai S,et al.The future of transcatheter mitral valve interventions:competitive or complementary role of repair vs. replacement?[J].Eur Heart J, 2015, 36(26):1651-1659.
[21]Ruiz CE,Kliger C,Perk G,et al.Transcatheter therapies for the treatment of valvular and paravalvular regurgitation in acquired and congenital valvular heart disease[J].J Am Coll Cardiol,2015,66(2):169-183.
[22]Wilbring M,Alexiou K,Tugtekin SM,et al.Pushing the limits-further evolutions of transcatheter valve procedures in the mitral position, including valve-in-valve,valve-in-ring,and valve-in-native-ring[J].J Thorac Cardiovasc Surg,2014,147(1):210-219.

备注/Memo

备注/Memo:
收稿日期：2015-12-26.基金项目：国家自然科学基金项目资助（81470500）;西京医院学科助推计划杰青培育项目资助（XJZT14J03） 通讯作者：杨剑，副教授，主要从事心脏瓣膜疾病微创和介入治疗研究 Email：yangjian@fmmu.edu.cn 作者简介：杨东涛，主治医师 Email：yangyang613@qq.com
更新日期/Last Update: 1900-01-01